Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iradimed (IRMD) Other Operating Expenses (2016 - 2025)

Iradimed (IRMD) has disclosed Other Operating Expenses for 13 consecutive years, with $4.6 million as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses rose 1.91% to $4.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.4 million through Dec 2025, up 11.55% year-over-year, with the annual reading at $203000.0 for FY2025, 5175.0% up from the prior year.
  • Other Operating Expenses for Q4 2025 was $4.6 million at Iradimed, down from $4.6 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $4.6 million in Q3 2025, with the low at $793716.0 in Q1 2023.
  • Average Other Operating Expenses over 5 years is $3.3 million, with a median of $3.2 million recorded in 2021.
  • The sharpest move saw Other Operating Expenses tumbled 74.14% in 2023, then surged 382.18% in 2024.
  • Over 5 years, Other Operating Expenses stood at $3.1 million in 2021, then increased by 17.43% to $3.7 million in 2022, then dropped by 9.16% to $3.3 million in 2023, then soared by 35.68% to $4.5 million in 2024, then grew by 1.91% to $4.6 million in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $4.6 million, $4.6 million, and $4.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.